Gross margin printed 39.4% in 2026Q3, bracketed by 36.0% in 2026Q1 and 46.1% in 2026Q2, against a much tighter 39.6%-41.5% band through 2024, so the mid-40s print appears to be the outlier rather than a new plateau. Operating margin of 14.8% in 2026Q3 is only modestly below the 15.7%-16.3% range of 2024, which suggests the underlying business is holding roughly its pre-volatility profitability while headline EPS whipsaws on non-operating factors. On that basis, normalized gross margin of about 40-41% paired with operating margin near 15-16% is the more defensible representation of Dorman's true earning power, with reported net margin likely unsuitable for underwriting.

Across the ten reported quarters ROIC has cycled between 2.2% and 4.5% without a directional trend, which reads as mean-reversion around a mid-3% quarterly level rather than the compounding or decay pattern an investor would normally underwrite. Because turnover has been pinned at 0.21-0.22 for two years, returns are almost wholly a function of gross margin, meaning tariff costs, freight swings and private-label encroachment at the Big Four are in effect direct threats to Dorman's return profile. Peer comparison should be treated cautiously as the peer table's ROIC figures for LKQ at 7.2% and ALSN at 22.2% appear to be annual measures while Dorman's are quarterly, so normalization is required before concluding Dorman either leads or lags the group.

DSO has stayed inside a relatively narrow 81-101 day band throughout, implying the Big Four customers' payment terms have not materially shifted and that the cycle extension is not a receivables story but an inventory positioning choice, with DIO peaking at 281 days in 2025Q4. The simultaneous shortening of DPO removes a customary source of supplier-funded working capital, so the cash absorbed here appears to be self-funded, which is consistent with the $366.9M working-capital drag identified across the ten reported quarters. With asset turnover stuck at 0.22, incremental revenue appears to require roughly proportional inventory investment, investors should monitor whether DIO moderates as retailers finish destocking or whether the elevated stock proves to be aging platforms.

The coverage swing from 4.60x to 19.30x across the window is far larger than the change in absolute debt, which per prior balance sheet work fell from $635.9M to $523.4M, so the volatility appears driven by earnings variability rather than balance-sheet restructuring. Debt-to-EBITDA at 5.41x in 2026Q3 remains above the 4.34x printed in 2026Q2 and reflects the same EBITDA denominator instability, meaning the leverage optics are more fragile than the low debt-to-equity ratio alone would suggest. Relative to LKQ's 0.77 debt-to-equity in the peer table Dorman looks conservatively financed, and refinancing risk appears contained on reported figures, though coverage would deteriorate quickly if the 2025Q4-style margin episode recurred.

The forward P/E of 14.35x versus 18.72x trailing embeds an approximate 30% earnings recovery, which warrants scrutiny given the most recent quarter's EPS declined 20.2% year-over-year and was accompanied by no refreshed guidance, so the multiple gap may be flattered by estimates rather than observed momentum. Against ALSN at 14.69x with a 20.7% net margin and 22.2% ROIC, Dorman's 18.72x on roughly 10.5% quarterly net margin looks demanding unless one credits the higher 41%-type gross margin as structurally superior to distribution peers. A PEG of 1.25 versus 0.64 for ALSN suggests the market is pricing Dorman as a growth compounder, a characterization that sits awkwardly alongside decelerating revenue growth and a flat ROIC trend.